Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1974 1
1975 3
1976 3
1977 4
1978 2
1979 3
1980 2
1982 1
1983 1
1986 1
1987 1
1989 1
1990 6
1991 4
1992 1
1993 1
1998 3
2000 1
2001 3
2003 10
2004 12
2005 7
2006 13
2007 16
2008 9
2009 10
2010 14
2011 13
2012 30
2013 28
2014 31
2015 44
2016 31
2017 46
2018 48
2019 47
2020 45
2021 54
2022 60
2023 52
2024 48
2025 61
2026 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

705 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant therapy for stage IIB + IIC melanoma.
Malekzadeh P, Brady MS. Malekzadeh P, et al. J Surg Oncol. 2024 Jan;129(1):91-96. doi: 10.1002/jso.27534. Epub 2023 Nov 30. J Surg Oncol. 2024. PMID: 38031847 No abstract available.
Waistline cincture.
Teimourian B, Adham MN, Malekzadeh S. Teimourian B, et al. Aesthet Surg J. 1998 Nov-Dec;18(6):458-60. doi: 10.1016/s1090-820x(98)70080-9. Aesthet Surg J. 1998. PMID: 19328178 No abstract available.
Cancer neoantigens targeted by adoptive T cell transfer: private no more.
Lugli E, Kvistborg P, Galletti G. Lugli E, et al. J Clin Invest. 2019 Mar 1;129(3):949-951. doi: 10.1172/JCI126295. Epub 2019 Feb 4. J Clin Invest. 2019. PMID: 30714989 Free PMC article.
Effector T cell responses directed toward cancer neoantigens mediate tumor regression following checkpoint blockade or adoptive T cell immunotherapy, but are generally "private", thus requiring considerable effort for their identification. In this issue of the JCI, Malekzadeh
Effector T cell responses directed toward cancer neoantigens mediate tumor regression following checkpoint blockade or adoptive T cell immun …
Authors' Reply.
Abtahi S, Malekzadeh M, Nikravan G, Ghaderi A. Abtahi S, et al. Int J Occup Environ Med. 2018 Jul;9(3):158-159. doi: 10.15171/ijoem.2018.1356. Int J Occup Environ Med. 2018. PMID: 29995023 Free PMC article. No abstract available.
Growth rate of left atrial myxoma.
Malekzadeh S, Roberts WC. Malekzadeh S, et al. Am J Cardiol. 1989 Nov 1;64(16):1075-6. doi: 10.1016/0002-9149(89)90819-9. Am J Cardiol. 1989. PMID: 2683708 Review. No abstract available.
705 results